Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China
Patients with obesity are at increased risk of exacerbations from viral respiratory infections. However, the association of obesity with the severity of coronavirus disease 2019 (COVID-19) is unclear. We examined this association using data from the only referral hospital in Shenzhen, China. A total...
Saved in:
| Published in | Diabetes care Vol. 43; no. 7; pp. 1392 - 1398 |
|---|---|
| Main Authors | , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
American Diabetes Association
01.07.2020
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Patients with obesity are at increased risk of exacerbations from viral respiratory infections. However, the association of obesity with the severity of coronavirus disease 2019 (COVID-19) is unclear. We examined this association using data from the only referral hospital in Shenzhen, China.
A total of 383 consecutively hospitalized patients with COVID-19 admitted from 11 January 2020 to 16 February 2020 and followed until 26 March 2020 at the Third People's Hospital of Shenzhen were included. Underweight was defined as a BMI <18.5 kg/m
, normal weight as 18.5-23.9 kg/m
, overweight as 24.0-27.9 kg/m
, and obesity as ≥28 kg/m
.
Of the 383 patients, 53.1% were normal weight, 4.2% were underweight, 32.0% were overweight, and 10.7% were obese at admission. Obese patients tended to have symptoms of cough (
= 0.03) and fever (
= 0.06) compared with patients who were not obese. Compared with normal weight patients, those who were overweight had 1.84-fold odds of developing severe COVID-19 (odds ratio [OR] 1.84, 95% CI 0.99-3.43,
= 0.05), while those who were obese were at 3.40-fold odds of developing severe disease (OR 3.40, 95% CI 1.40-2.86,
= 0.007), after adjusting for age, sex, epidemiological characteristics, days from disease onset to hospitalization, presence of hypertension, diabetes, cardiovascular disease, chronic obstructive pulmonary disease, liver disease, and cancer, and drug used for treatment. Additionally, after similar adjustment, men who were obese versus those who were normal weight were at increased odds of developing severe COVID-19 (OR 5.66, 95% CI 1.80-17.75,
= 0.003).
In this study, obese patients had increased odds of progressing to severe COVID-19. As the severe acute respiratory syndrome coronavirus 2 may continue to spread worldwide, clinicians should pay close attention to obese patients, who should be carefully managed with prompt and aggressive treatment. |
|---|---|
| AbstractList | Patients with obesity are at increased risk of exacerbations from viral respiratory infections. However, the association of obesity with the severity of coronavirus disease 2019 (COVID-19) is unclear. We examined this association using data from the only referral hospital in Shenzhen, China.OBJECTIVEPatients with obesity are at increased risk of exacerbations from viral respiratory infections. However, the association of obesity with the severity of coronavirus disease 2019 (COVID-19) is unclear. We examined this association using data from the only referral hospital in Shenzhen, China.A total of 383 consecutively hospitalized patients with COVID-19 admitted from 11 January 2020 to 16 February 2020 and followed until 26 March 2020 at the Third People's Hospital of Shenzhen were included. Underweight was defined as a BMI <18.5 kg/m2, normal weight as 18.5-23.9 kg/m2, overweight as 24.0-27.9 kg/m2, and obesity as ≥28 kg/m2.RESEARCH DESIGN AND METHODSA total of 383 consecutively hospitalized patients with COVID-19 admitted from 11 January 2020 to 16 February 2020 and followed until 26 March 2020 at the Third People's Hospital of Shenzhen were included. Underweight was defined as a BMI <18.5 kg/m2, normal weight as 18.5-23.9 kg/m2, overweight as 24.0-27.9 kg/m2, and obesity as ≥28 kg/m2.Of the 383 patients, 53.1% were normal weight, 4.2% were underweight, 32.0% were overweight, and 10.7% were obese at admission. Obese patients tended to have symptoms of cough (P = 0.03) and fever (P = 0.06) compared with patients who were not obese. Compared with normal weight patients, those who were overweight had 1.84-fold odds of developing severe COVID-19 (odds ratio [OR] 1.84, 95% CI 0.99-3.43, P = 0.05), while those who were obese were at 3.40-fold odds of developing severe disease (OR 3.40, 95% CI 1.40-2.86, P = 0.007), after adjusting for age, sex, epidemiological characteristics, days from disease onset to hospitalization, presence of hypertension, diabetes, cardiovascular disease, chronic obstructive pulmonary disease, liver disease, and cancer, and drug used for treatment. Additionally, after similar adjustment, men who were obese versus those who were normal weight were at increased odds of developing severe COVID-19 (OR 5.66, 95% CI 1.80-17.75, P = 0.003).RESULTSOf the 383 patients, 53.1% were normal weight, 4.2% were underweight, 32.0% were overweight, and 10.7% were obese at admission. Obese patients tended to have symptoms of cough (P = 0.03) and fever (P = 0.06) compared with patients who were not obese. Compared with normal weight patients, those who were overweight had 1.84-fold odds of developing severe COVID-19 (odds ratio [OR] 1.84, 95% CI 0.99-3.43, P = 0.05), while those who were obese were at 3.40-fold odds of developing severe disease (OR 3.40, 95% CI 1.40-2.86, P = 0.007), after adjusting for age, sex, epidemiological characteristics, days from disease onset to hospitalization, presence of hypertension, diabetes, cardiovascular disease, chronic obstructive pulmonary disease, liver disease, and cancer, and drug used for treatment. Additionally, after similar adjustment, men who were obese versus those who were normal weight were at increased odds of developing severe COVID-19 (OR 5.66, 95% CI 1.80-17.75, P = 0.003).In this study, obese patients had increased odds of progressing to severe COVID-19. As the severe acute respiratory syndrome coronavirus 2 may continue to spread worldwide, clinicians should pay close attention to obese patients, who should be carefully managed with prompt and aggressive treatment.CONCLUSIONSIn this study, obese patients had increased odds of progressing to severe COVID-19. As the severe acute respiratory syndrome coronavirus 2 may continue to spread worldwide, clinicians should pay close attention to obese patients, who should be carefully managed with prompt and aggressive treatment. OBJECTIVE Patients with obesity are at increased risk of exacerbations from viral respiratory infections. However, the association of obesity with the severity of coronavirus disease 2019 (COVID-19) is unclear. We examined this association using data from the only referral hospital in Shenzhen, China. RESEARCH DESIGN AND METHODS A total of 383 consecutively hospitalized patients with COVID-19 admitted from 11 January 2020 to 16 February 2020 and followed until 26 March 2020 at the Third People's Hospital of Shenzhen were included. Underweight was defined as a BMI <18.5 kg/m2, normal weight as 18.5–23.9 kg/m2, overweight as 24.0–27.9 kg/m2, and obesity as ≥28 kg/m2. RESULTS Of the 383 patients, 53.1% were normal weight, 4.2% were underweight, 32.0% were overweight, and 10.7% were obese at admission. Obese patients tended to have symptoms of cough (P = 0.03) and fever (P = 0.06) compared with patients who were not obese. Compared with normal weight patients, those who were overweight had 1.84-fold odds of developing severe COVID-19 (odds ratio [OR] 1.84, 95% CI 0.99–3.43, P = 0.05), while those who were obese were at 3.40-fold odds of developing severe disease (OR 3.40, 95% CI 1.40–2.86, P = 0.007), after adjusting for age, sex, epidemiological characteristics, days from disease onset to hospitalization, presence of hypertension, diabetes, cardiovascular disease, chronic obstructive pulmonary disease, liver disease, and cancer, and drug used for treatment. Additionally, after similar adjustment, men who were obese versus those who were normal weight were at increased odds of developing severe COVID-19 (OR 5.66, 95% CI 1.80–17.75, P = 0.003). CONCLUSIONS In this study, obese patients had increased odds of progressing to severe COVID-19. As the severe acute respiratory syndrome coronavirus 2 may continue to spread worldwide, clinicians should pay close attention to obese patients, who should be carefully managed with prompt and aggressive treatment. Patients with obesity are at increased risk of exacerbations from viral respiratory infections. However, the association of obesity with the severity of coronavirus disease 2019 (COVID-19) is unclear. We examined this association using data from the only referral hospital in Shenzhen, China. A total of 383 consecutively hospitalized patients with COVID-19 admitted from 11 January 2020 to 16 February 2020 and followed until 26 March 2020 at the Third People's Hospital of Shenzhen were included. Underweight was defined as a BMI <18.5 kg/m , normal weight as 18.5-23.9 kg/m , overweight as 24.0-27.9 kg/m , and obesity as ≥28 kg/m . Of the 383 patients, 53.1% were normal weight, 4.2% were underweight, 32.0% were overweight, and 10.7% were obese at admission. Obese patients tended to have symptoms of cough ( = 0.03) and fever ( = 0.06) compared with patients who were not obese. Compared with normal weight patients, those who were overweight had 1.84-fold odds of developing severe COVID-19 (odds ratio [OR] 1.84, 95% CI 0.99-3.43, = 0.05), while those who were obese were at 3.40-fold odds of developing severe disease (OR 3.40, 95% CI 1.40-2.86, = 0.007), after adjusting for age, sex, epidemiological characteristics, days from disease onset to hospitalization, presence of hypertension, diabetes, cardiovascular disease, chronic obstructive pulmonary disease, liver disease, and cancer, and drug used for treatment. Additionally, after similar adjustment, men who were obese versus those who were normal weight were at increased odds of developing severe COVID-19 (OR 5.66, 95% CI 1.80-17.75, = 0.003). In this study, obese patients had increased odds of progressing to severe COVID-19. As the severe acute respiratory syndrome coronavirus 2 may continue to spread worldwide, clinicians should pay close attention to obese patients, who should be carefully managed with prompt and aggressive treatment. |
| Author | Liu, Yingxia Cai, Qingxian Wu, Qikai Wang, Zhaoqin Xu, Lin Chen, Jun Luo, Fang Chen, Fengjuan He, Qing Wang, Tao Liu, Xiaohui Liu, Lei |
| Author_xml | – sequence: 1 givenname: Qingxian surname: Cai fullname: Cai, Qingxian organization: National Clinical Research Center for Infectious Diseases, The Third People’s Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China – sequence: 2 givenname: Fengjuan surname: Chen fullname: Chen, Fengjuan organization: Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou, China – sequence: 3 givenname: Tao surname: Wang fullname: Wang, Tao organization: School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong, China – sequence: 4 givenname: Fang surname: Luo fullname: Luo, Fang organization: National Clinical Research Center for Infectious Diseases, The Third People’s Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China – sequence: 5 givenname: Xiaohui surname: Liu fullname: Liu, Xiaohui organization: National Clinical Research Center for Infectious Diseases, The Third People’s Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China – sequence: 6 givenname: Qikai surname: Wu fullname: Wu, Qikai organization: National Clinical Research Center for Infectious Diseases, The Third People’s Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China – sequence: 7 givenname: Qing surname: He fullname: He, Qing organization: National Clinical Research Center for Infectious Diseases, The Third People’s Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China – sequence: 8 givenname: Zhaoqin surname: Wang fullname: Wang, Zhaoqin organization: National Clinical Research Center for Infectious Diseases, The Third People’s Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China – sequence: 9 givenname: Yingxia surname: Liu fullname: Liu, Yingxia organization: National Clinical Research Center for Infectious Diseases, The Third People’s Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China – sequence: 10 givenname: Lei surname: Liu fullname: Liu, Lei organization: National Clinical Research Center for Infectious Diseases, The Third People’s Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China – sequence: 11 givenname: Jun orcidid: 0000-0002-9744-792X surname: Chen fullname: Chen, Jun organization: National Clinical Research Center for Infectious Diseases, The Third People’s Hospital of Shenzhen, The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China – sequence: 12 givenname: Lin orcidid: 0000-0002-0537-922X surname: Xu fullname: Xu, Lin organization: School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32409502$$D View this record in MEDLINE/PubMed |
| BookMark | eNplkUtLw0AQxxdRtK0e_AIS8KJgdPaVZI4SX4VCDz6uy2az1Ui6qdlEqJ_eDW0vyjAMzPxmmJn_mOy7xllCTilcM87Tm9IwiEGmyR4ZUeQyllJk-2QEVGAsEdkRGXv_CQBCZNkhOeJMAEpgIzKdF9ZX3TrSrozy-dv0LqYYPdtv2w7ZykU6ugvEu9OdLaOnxq-qTtdD4fnDup_gV1H-UTl9TA4Wuvb2ZBsn5PXh_iV_imfzx2l-O4sNT7GLdZEkKG2SAkNETqUpeJpawKIwyARyAbpMUZRIAUW6sGxhQGS8RJMBaM4n5GIzd9U2X731nVpW3ti61s42vVfhtGCSShHQ8z_oZ9O3LmwXKJpIRkGwQJ1tqb5Y2lKt2mqp27XaPSkANxvAtI33rV0oE37QVY3rWl3VioIaZFCDDGqQIXRc_unYDf3P_gKYCIKw |
| CitedBy_id | crossref_primary_10_1089_vim_2021_0150 crossref_primary_10_21518_2307_1109_2021_11_1_58_66 crossref_primary_10_3390_healthcare11091220 crossref_primary_10_1371_journal_pone_0250602 crossref_primary_10_5812_ans_140959 crossref_primary_10_1108_NFS_10_2022_0360 crossref_primary_10_3390_ijerph17249336 crossref_primary_10_3390_jcm11082250 crossref_primary_10_2147_IDR_S319029 crossref_primary_10_1016_j_jdiacomp_2020_107817 crossref_primary_10_1016_j_foodchem_2021_130994 crossref_primary_10_1136_jim_2021_001871 crossref_primary_10_1007_s11010_022_04356_w crossref_primary_10_1016_j_clnesp_2021_06_002 crossref_primary_10_1111_all_14657 crossref_primary_10_18678_dtfd_1192388 crossref_primary_10_1016_j_pcd_2020_06_010 crossref_primary_10_14336_AD_2020_0630 crossref_primary_10_3201_eid2705_204507 crossref_primary_10_1055_s_0042_1743258 crossref_primary_10_1161_CIRCULATIONAHA_121_054075 crossref_primary_10_1038_s41598_022_16260_w crossref_primary_10_1155_adph_4456532 crossref_primary_10_1016_j_diabres_2020_108304 crossref_primary_10_1007_s12020_021_02619_y crossref_primary_10_1016_j_aohep_2020_100295 crossref_primary_10_3389_fimmu_2020_594963 crossref_primary_10_7570_jomes20056 crossref_primary_10_1016_j_aohep_2021_100348 crossref_primary_10_1016_j_semerg_2022_101840 crossref_primary_10_3389_fcimb_2025_1513687 crossref_primary_10_2147_JMDH_S361061 crossref_primary_10_1080_03670244_2021_1968849 crossref_primary_10_1093_cei_uxac079 crossref_primary_10_2337_dci20_0034 crossref_primary_10_1016_j_metabol_2020_154378 crossref_primary_10_1111_cob_12403 crossref_primary_10_1172_jci_insight_166110 crossref_primary_10_7554_eLife_61330 crossref_primary_10_1016_j_metabol_2021_154894 crossref_primary_10_17116_profmed20222505179 crossref_primary_10_1097_JOM_0000000000002118 crossref_primary_10_1111_obr_13165 crossref_primary_10_1016_j_jval_2021_05_013 crossref_primary_10_1186_s12877_020_01803_5 crossref_primary_10_1002_osp4_477 crossref_primary_10_2337_dbi21_0029 crossref_primary_10_3390_diagnostics12123196 crossref_primary_10_1007_s10389_020_01468_9 crossref_primary_10_20945_2359_3997000000351 crossref_primary_10_1016_j_clnu_2020_10_023 crossref_primary_10_36502_2020_asjpch_6160 crossref_primary_10_1111_ijcp_13886 crossref_primary_10_2337_dci20_0024 crossref_primary_10_1186_s12902_023_01351_0 crossref_primary_10_1016_j_heliyon_2024_e36610 crossref_primary_10_1186_s12889_021_11546_6 crossref_primary_10_1007_s12291_020_00909_2 crossref_primary_10_3390_jcm11143933 crossref_primary_10_1002_ajhb_23484 crossref_primary_10_1007_s10620_021_07104_0 crossref_primary_10_3390_ijerph18115682 crossref_primary_10_1080_00036846_2021_1884838 crossref_primary_10_1016_j_ajem_2020_10_022 crossref_primary_10_18772_26180197_2020_v2n3a5 crossref_primary_10_1038_s41598_021_86694_1 crossref_primary_10_1111_cob_12663 crossref_primary_10_1515_tjb_2021_0297 crossref_primary_10_2174_1573405620666230511093259 crossref_primary_10_1210_endocr_bqac139 crossref_primary_10_4103_2231_9409_328221 crossref_primary_10_1002_hep_31480 crossref_primary_10_3390_healthcare10122575 crossref_primary_10_1007_s12016_022_08921_5 crossref_primary_10_2337_dc20_1195 crossref_primary_10_1007_s12020_021_02728_8 crossref_primary_10_1002_ptr_7085 crossref_primary_10_1038_s41598_022_13424_6 crossref_primary_10_1016_j_xcrm_2021_100218 crossref_primary_10_1016_j_obmed_2024_100538 crossref_primary_10_1016_j_hnm_2022_200179 crossref_primary_10_1016_j_diabres_2020_108346 crossref_primary_10_1016_j_isci_2025_111837 crossref_primary_10_1038_s41440_020_0515_0 crossref_primary_10_1002_edm2_176 crossref_primary_10_3390_diseases10040099 crossref_primary_10_30629_0023_2149_2023_101_6_265_274 crossref_primary_10_3390_life14030343 crossref_primary_10_3389_fmed_2022_1036556 crossref_primary_10_3390_su13095305 crossref_primary_10_12998_wjcc_v9_i1_8 crossref_primary_10_29254_2077_4214_2024_4_175_450_457 crossref_primary_10_1542_hpeds_2021_006087 crossref_primary_10_4102_sajid_v36i1_228 crossref_primary_10_17476_jmbs_2021_10_1_1 crossref_primary_10_1016_j_jjcc_2021_09_013 crossref_primary_10_1079_PAVSNNR202116016 crossref_primary_10_1111_1753_0407_13085 crossref_primary_10_1016_j_npg_2021_02_001 crossref_primary_10_1055_s_0042_1759889 crossref_primary_10_1055_s_0041_1728680 crossref_primary_10_1007_s12011_020_02546_5 crossref_primary_10_3390_pathogens9110887 crossref_primary_10_1016_j_micinf_2021_104913 crossref_primary_10_1111_cea_13746 crossref_primary_10_1186_s12931_020_01510_0 crossref_primary_10_1007_s13105_022_00887_4 crossref_primary_10_1055_s_0044_1782166 crossref_primary_10_1097_MPG_0000000000003077 crossref_primary_10_1002_mnfr_202200576 crossref_primary_10_1017_S0950268820003179 crossref_primary_10_5049_EBP_2020_18_2_23 crossref_primary_10_1002_JLB_5HI1020_704R crossref_primary_10_1055_a_1326_2125 crossref_primary_10_3748_wjg_v27_i6_449 crossref_primary_10_2337_dc20_1714 crossref_primary_10_1007_s10787_021_00835_6 crossref_primary_10_3390_ijerph19031125 crossref_primary_10_17816_CS626503 crossref_primary_10_1007_s11739_021_02882_x crossref_primary_10_1016_j_tmaid_2020_101923 crossref_primary_10_1097_MOP_0000000000000953 crossref_primary_10_3389_fcimb_2020_575559 crossref_primary_10_3389_fcell_2021_659032 crossref_primary_10_1007_s11332_023_01148_7 crossref_primary_10_1016_j_clnu_2021_02_038 crossref_primary_10_1186_s12872_021_02134_y crossref_primary_10_3390_jcm11175155 crossref_primary_10_1016_j_cpcardiol_2022_101417 crossref_primary_10_36106_ijsr_9602995 crossref_primary_10_1038_s41598_023_33314_9 crossref_primary_10_1002_pdi_2290 crossref_primary_10_1152_physrev_00035_2020 crossref_primary_10_1080_20477724_2021_1984726 crossref_primary_10_23736_S1973_9087_21_06674_0 crossref_primary_10_1016_j_mmm_2020_05_009 crossref_primary_10_3389_fnut_2021_649422 crossref_primary_10_1016_j_orcp_2021_10_006 crossref_primary_10_2217_fvl_2021_0257 crossref_primary_10_1007_s11596_021_2442_y crossref_primary_10_1002_dmrr_3519 crossref_primary_10_1111_cei_13523 crossref_primary_10_1016_j_amsu_2020_12_045 crossref_primary_10_1017_S0950268820003027 crossref_primary_10_1002_mco2_66 crossref_primary_10_1055_a_1552_4449 crossref_primary_10_1002_jmv_28130 crossref_primary_10_1159_000531792 crossref_primary_10_2147_DMSO_S285197 crossref_primary_10_3390_jpm11030227 crossref_primary_10_1016_j_orcp_2021_05_001 crossref_primary_10_1177_17534666211025221 crossref_primary_10_1002_edm2_338 crossref_primary_10_1007_s00464_021_08314_3 crossref_primary_10_4103_mjdrdypu_mjdrdypu_282_20 crossref_primary_10_1515_dx_2020_0111 crossref_primary_10_1155_2022_9908450 crossref_primary_10_1002_oby_22979 crossref_primary_10_1371_journal_pone_0265473 crossref_primary_10_1007_s13679_021_00432_2 crossref_primary_10_1016_j_jjcc_2022_08_011 crossref_primary_10_3390_jcm11030622 crossref_primary_10_1007_s11205_021_02699_3 crossref_primary_10_1111_resp_14049 crossref_primary_10_1016_j_cbi_2022_109898 crossref_primary_10_3390_ijms21165793 crossref_primary_10_3389_fnut_2022_906659 crossref_primary_10_3389_fendo_2022_780872 crossref_primary_10_2337_db20_0671 crossref_primary_10_1038_s41374_022_00783_x crossref_primary_10_25048_tudod_751846 crossref_primary_10_1111_dom_14523 crossref_primary_10_1016_j_arcmed_2020_12_002 crossref_primary_10_1177_1753466620971146 crossref_primary_10_17816_PED1255_25 crossref_primary_10_3389_fimmu_2023_1231363 crossref_primary_10_1111_aas_13726 crossref_primary_10_7759_cureus_27438 crossref_primary_10_5582_bst_2021_01090 crossref_primary_10_1371_journal_pone_0251085 crossref_primary_10_1016_j_ejim_2021_03_031 crossref_primary_10_1080_21620555_2021_1934824 crossref_primary_10_1002_jcsm_12674 crossref_primary_10_3390_microorganisms9061292 crossref_primary_10_1002_ctm2_949 crossref_primary_10_1039_D3MA00159H crossref_primary_10_1155_2022_5452488 crossref_primary_10_1146_annurev_resource_022823_033521 crossref_primary_10_3389_fendo_2020_595109 crossref_primary_10_3389_fimmu_2020_574029 crossref_primary_10_5937_jomb0_47588 crossref_primary_10_1016_j_tifs_2022_02_017 crossref_primary_10_1002_oby_22946 crossref_primary_10_3389_fendo_2020_600439 crossref_primary_10_1016_j_jhep_2020_06_041 crossref_primary_10_1002_oby_22947 crossref_primary_10_1186_s12979_020_00212_x crossref_primary_10_7762_cnr_2022_11_4_331 crossref_primary_10_26453_otjhs_798631 crossref_primary_10_1007_s00592_020_01636_z crossref_primary_10_1016_j_ccrj_2023_10_004 crossref_primary_10_1016_j_ssaho_2021_100224 crossref_primary_10_1016_j_numecd_2020_11_030 crossref_primary_10_1038_s41598_021_83226_9 crossref_primary_10_4103_jfmpc_jfmpc_181_21 crossref_primary_10_4239_wjd_v13_i9_729 crossref_primary_10_1186_s12992_021_00767_4 crossref_primary_10_1530_JME_22_0036 crossref_primary_10_1016_j_jhepr_2020_100169 crossref_primary_10_1038_s41366_021_00872_9 crossref_primary_10_3390_tomography8060234 crossref_primary_10_3389_fnut_2022_931313 crossref_primary_10_1017_S0269888923000036 crossref_primary_10_3390_su14116498 crossref_primary_10_3389_fpubh_2021_711616 crossref_primary_10_4103_jncd_jncd_7_21 crossref_primary_10_1111_dth_13989 crossref_primary_10_54005_geneltip_1287570 crossref_primary_10_1038_s41598_022_21814_z crossref_primary_10_3390_biology11020215 crossref_primary_10_1002_oby_22883 crossref_primary_10_2337_dc20_1543 crossref_primary_10_1177_00185787231220318 crossref_primary_10_3390_idr16050071 crossref_primary_10_1186_s13098_020_00586_4 crossref_primary_10_1001_jamanetworkopen_2020_22310 crossref_primary_10_1007_s10140_021_01998_z crossref_primary_10_1080_08998280_2024_2358294 crossref_primary_10_3748_wjg_v28_i48_6875 crossref_primary_10_1136_bmjopen_2024_089508 crossref_primary_10_1038_s41574_023_00833_4 crossref_primary_10_1016_j_numecd_2020_11_012 crossref_primary_10_2147_DMSO_S262888 crossref_primary_10_1016_j_amepre_2020_10_015 crossref_primary_10_1016_j_cegh_2020_10_005 crossref_primary_10_3390_pathogens11050563 crossref_primary_10_1016_j_bcp_2022_115370 crossref_primary_10_1186_s12950_023_00333_2 crossref_primary_10_2174_26669587_v2_e2207050 crossref_primary_10_1007_s00705_021_05012_2 crossref_primary_10_1183_13993003_02108_2020 crossref_primary_10_1177_14799731241259749 crossref_primary_10_1177_20406223241310206 crossref_primary_10_37699_2308_7005_6_2023_03 crossref_primary_10_1111_bph_15229 crossref_primary_10_3389_fnut_2022_927092 crossref_primary_10_1007_s10903_021_01189_5 crossref_primary_10_3390_jcm10163581 crossref_primary_10_3389_fimmu_2022_890517 crossref_primary_10_1161_CIR_0000000000001052 crossref_primary_10_1002_jmv_26252 crossref_primary_10_1007_s11101_021_09759_z crossref_primary_10_1016_j_eclinm_2023_102031 crossref_primary_10_1186_s12933_022_01569_7 crossref_primary_10_1097_CRD_0000000000000405 crossref_primary_10_7759_cureus_13687 crossref_primary_10_1109_ACCESS_2020_3037912 crossref_primary_10_1007_s11695_020_04919_0 crossref_primary_10_1093_jpids_piaa045 crossref_primary_10_32895_UMP_MPR_6_4_6 crossref_primary_10_1590_s1679_49742021000300004 crossref_primary_10_15656_kjcg_2020_21_2_54 crossref_primary_10_1097_CNQ_0000000000000346 crossref_primary_10_3389_fphys_2020_572718 crossref_primary_10_1016_j_healthplace_2021_102659 crossref_primary_10_1016_j_heliyon_2023_e13801 crossref_primary_10_1093_ofid_ofab275 crossref_primary_10_2174_2452271604999210104222642 crossref_primary_10_1155_2022_1571826 crossref_primary_10_1007_s40519_021_01269_3 crossref_primary_10_1007_s40745_022_00378_9 crossref_primary_10_2174_1573403X18666220509154236 crossref_primary_10_1371_journal_pone_0243888 crossref_primary_10_1016_j_vaccine_2024_126582 crossref_primary_10_1093_jpids_piaa175 crossref_primary_10_1111_jth_15072 crossref_primary_10_1016_j_endinu_2020_10_001 crossref_primary_10_1152_physrev_00030_2020 crossref_primary_10_3390_healthcare12070747 crossref_primary_10_1111_dom_14228 crossref_primary_10_3389_fcvm_2023_1062491 crossref_primary_10_1186_s12245_022_00431_7 crossref_primary_10_17116_repro20212703228 crossref_primary_10_17816_pmj41181_89 crossref_primary_10_1080_17482631_2023_2256669 crossref_primary_10_3390_ijerph19052958 crossref_primary_10_1097_MD_0000000000040505 crossref_primary_10_1507_endocrj_EJ20_0784 crossref_primary_10_17533_udea_iatreia_256 crossref_primary_10_1016_j_yjmcc_2020_08_007 crossref_primary_10_1177_09720634221150866 crossref_primary_10_1007_s11695_021_05799_8 crossref_primary_10_1038_s41598_021_02370_4 crossref_primary_10_1590_1516_3180_2021_1038_r1_06072022 crossref_primary_10_1016_j_biopha_2022_113178 crossref_primary_10_3390_healthcare10050780 crossref_primary_10_1038_s41579_021_00542_7 crossref_primary_10_7554_eLife_66522 crossref_primary_10_1016_j_metabol_2020_154436 crossref_primary_10_1177_27541223221111500 crossref_primary_10_3389_fendo_2023_1128622 crossref_primary_10_1002_oby_23223 crossref_primary_10_3389_fimmu_2020_570251 crossref_primary_10_3389_fpubh_2023_1156782 crossref_primary_10_3390_nu13062060 crossref_primary_10_1016_j_obmed_2020_100284 crossref_primary_10_3389_fphys_2022_1030568 crossref_primary_10_1097_ACI_0000000000000783 crossref_primary_10_1007_s43762_024_00160_y crossref_primary_10_1016_j_brat_2022_104141 crossref_primary_10_1016_j_jiph_2023_02_002 crossref_primary_10_21886_2712_8156_2021_2_1_17_24 crossref_primary_10_3390_jcm10091947 crossref_primary_10_4103_2221_6189_342664 crossref_primary_10_1007_s10620_021_07324_4 crossref_primary_10_3346_jkms_2022_37_e103 crossref_primary_10_1007_s40519_021_01173_w crossref_primary_10_3390_biology9090280 crossref_primary_10_7759_cureus_55571 crossref_primary_10_1016_j_obpill_2024_100101 crossref_primary_10_15829_1560_4071_2022_4835 crossref_primary_10_1016_j_puhip_2025_100585 crossref_primary_10_1093_jn_nxaa375 crossref_primary_10_1016_j_micinf_2021_104780 crossref_primary_10_1002_rth2_12406 crossref_primary_10_18632_aging_202813 crossref_primary_10_1080_20477724_2022_2151861 crossref_primary_10_3390_ijms22137127 crossref_primary_10_1177_03000605241281907 crossref_primary_10_7759_cureus_21403 crossref_primary_10_3390_ijerph18041502 crossref_primary_10_1056_NEJMcp2009249 crossref_primary_10_1016_j_obmed_2021_100340 crossref_primary_10_1016_j_orcp_2021_02_006 crossref_primary_10_1053_j_gastro_2020_05_048 crossref_primary_10_1093_jpids_piaa115 crossref_primary_10_1097_CD9_0000000000000038 crossref_primary_10_3390_hygiene2040017 crossref_primary_10_1016_j_clinimag_2021_06_034 crossref_primary_10_12998_wjcc_v10_i15_4785 crossref_primary_10_3389_fnut_2022_896021 crossref_primary_10_1007_s40200_021_00822_2 crossref_primary_10_3233_MNM_210006 crossref_primary_10_23946_2500_0764_2022_7_4_29_44 crossref_primary_10_1016_j_metabol_2020_154408 crossref_primary_10_1155_2021_6666114 crossref_primary_10_1016_j_endien_2020_10_006 crossref_primary_10_1093_postmj_qgad008 crossref_primary_10_1002_path_5471 crossref_primary_10_1371_journal_pone_0272133 crossref_primary_10_7759_cureus_33734 crossref_primary_10_1016_j_amjms_2021_11_001 crossref_primary_10_1210_endocr_bqaa112 crossref_primary_10_3346_jkms_2023_38_e93 crossref_primary_10_3390_ijerph181910362 crossref_primary_10_4162_nrp_2021_15_S1_S41 crossref_primary_10_14341_omet12745 crossref_primary_10_1016_j_biochi_2022_01_005 crossref_primary_10_1155_2022_4320120 crossref_primary_10_1038_s41574_020_00462_1 crossref_primary_10_3389_fimmu_2021_625495 crossref_primary_10_1038_s41366_021_00776_8 crossref_primary_10_7759_cureus_22203 crossref_primary_10_1016_j_jiac_2022_12_004 crossref_primary_10_1093_nutrit_nuaa067 crossref_primary_10_24171_j_phrp_2021_0012 crossref_primary_10_1038_s41366_021_00907_1 crossref_primary_10_3390_jcm10245865 crossref_primary_10_12688_f1000research_74363_1 crossref_primary_10_1111_dom_14194 crossref_primary_10_12688_f1000research_74363_2 crossref_primary_10_2147_IDR_S426440 crossref_primary_10_1186_s40001_020_00464_9 crossref_primary_10_18231_j_ijogr_2022_008 crossref_primary_10_3389_fcell_2021_676150 crossref_primary_10_3389_fcimb_2021_712530 crossref_primary_10_1080_22221751_2022_2122581 crossref_primary_10_1093_infdis_jiaa663 crossref_primary_10_7759_cureus_72097 crossref_primary_10_37989_gumussagbil_1093669 crossref_primary_10_5812_jcrps_133320 crossref_primary_10_1177_02761467211054354 crossref_primary_10_1016_j_metabol_2020_154345 crossref_primary_10_3389_fpubh_2021_584182 crossref_primary_10_7759_cureus_46943 crossref_primary_10_3390_info14080448 crossref_primary_10_1016_j_nurpra_2020_12_021 crossref_primary_10_1016_j_soard_2020_05_020 crossref_primary_10_1002_erv_2770 crossref_primary_10_1186_s12884_024_07025_6 crossref_primary_10_3390_cells10061412 crossref_primary_10_3390_ijerph192315645 crossref_primary_10_15366_rimcafd2022_88_017 crossref_primary_10_3947_ic_2021_0026 crossref_primary_10_1016_j_orcp_2021_01_004 crossref_primary_10_1002_14651858_CD015201 crossref_primary_10_1002_oby_23007 crossref_primary_10_1007_s11739_020_02616_5 crossref_primary_10_1007_s12325_021_01890_9 crossref_primary_10_1002_hep_31649 crossref_primary_10_3390_v13061025 crossref_primary_10_1172_JCI143648 crossref_primary_10_1080_17476348_2021_1866547 crossref_primary_10_3389_fimmu_2021_649359 crossref_primary_10_3389_fendo_2021_598249 crossref_primary_10_1002_jmv_26306 crossref_primary_10_1111_jan_14558 crossref_primary_10_1016_j_gpb_2021_09_004 crossref_primary_10_5009_gnl20267 crossref_primary_10_1002_oby_23111 crossref_primary_10_1002_jmv_26677 crossref_primary_10_1016_j_obmed_2022_100431 crossref_primary_10_18087_cardio_2021_4_n1408 crossref_primary_10_1007_s11906_021_01153_6 crossref_primary_10_3947_ic_2021_0140 |
| Cites_doi | 10.1111/dme.13378 10.1161/CIRCULATIONAHA.109.192575 10.1038/s41598-020-58633-z 10.1016/S0140-6736(20)30211-7 10.15557/PiMR.2020.0003 10.1016/j.jinf.2020.02.018 10.1001/archinte.160.20.3082 10.1080/17476348.2018.1506331 10.1016/j.jinf.2020.02.016 10.1007/s00125-017-4396-y 10.1093/cid/ciq152 10.3201/eid2606.200239 10.1164/rccm.201908-1581ST 10.1097/01.CCM.0000297885.60037.6E 10.1007/s11427-020-1643-8 10.1007/s11427-020-1668-5 10.1016/j.jinf.2009.03.007 10.1513/AnnalsATS.201706-447AW 10.1378/chest.06-1709 10.1097/01.CCM.0000256842.39767.41 10.1001/jama.2020.2565 10.1056/NEJMp2002125 10.1038/ijo.2011.208 10.1111/j.1440-1843.2011.02099.x 10.1371/journal.pone.0009694 10.1016/S0140-6736(03)15268-3 |
| ContentType | Journal Article |
| Copyright | 2020 by the American Diabetes Association. Copyright American Diabetes Association Jul 1, 2020 |
| Copyright_xml | – notice: 2020 by the American Diabetes Association. – notice: Copyright American Diabetes Association Jul 1, 2020 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. NAPCQ 7X8 |
| DOI | 10.2337/dc20-0576 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1935-5548 |
| EndPage | 1398 |
| ExternalDocumentID | 32409502 10_2337_dc20_0576 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | China Shenzhen China |
| GeographicLocations_xml | – name: China – name: Shenzhen China |
| GroupedDBID | --- -ET ..I .XZ 08P 0R~ 18M 29F 2WC 4.4 53G 5GY 5RE 5RS 5VS 6PF 8R4 8R5 AAFWJ AAIKC AAMNW AAWTL AAYEP AAYXX ABOCM ABPPZ ACGFO ACGOD ADBBV AEGXH AENEX AERZD AFOSN AFRAH AHMBA AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BENPR BTFSW CITATION CS3 DIK DU5 E3Z EBS EDB EMOBN EX3 F5P GX1 H13 HZ~ IAO IEA IHR INH INR IOF IPO KQ8 L7B M0K M5~ O5R O5S O9- OK1 OVD P2P PCD Q2X RHI SV3 TDI TEORI TR2 TWZ VVN W8F WH7 WOQ WOW YHG YOC ZCG ~KM .55 .GJ 3O- 3V. 41~ 7RV 7X2 7X7 88E 88I 8AF 8AO 8C1 8F7 8FE 8FH 8FI 8FJ 8G5 AAKAS AAQOH AAQQT AAYJJ ABUWG ADZCM AFFNX AFKRA AI. AN0 AQUVI ATCPS AZQEC BCR BCU BEC BHPHI BKEYQ BKNYI BLC BNQBC BPHCQ BVXVI C1A CCPQU CGR CUY CVF DWQXO ECM EIF EJD FYUFA GNUQQ GUQSH HCIFZ HMCUK IAG IGG ITC J5H K9- M0R M0T M1P M2O M2P M2Q N4W NAPCQ NPM PEA PQQKQ PROAC PSQYO RHF S0X SJFOW UKHRP VH1 VXZ WHG X7M ZGI ZXP K9. 7X8 |
| ID | FETCH-LOGICAL-c379t-ab6695e6702999315cb377e09bbc9249340ad794d910947fe2fc0483d9c800a33 |
| ISSN | 0149-5992 1935-5548 |
| IngestDate | Thu Jul 10 23:29:56 EDT 2025 Mon Jun 30 12:45:10 EDT 2025 Wed Feb 19 02:30:33 EST 2025 Tue Jul 01 04:12:00 EDT 2025 Thu Apr 24 23:13:18 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| License | 2020 by the American Diabetes Association. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c379t-ab6695e6702999315cb377e09bbc9249340ad794d910947fe2fc0483d9c800a33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-0537-922X 0000-0002-9744-792X |
| PMID | 32409502 |
| PQID | 2416521042 |
| PQPubID | 47715 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_2404045154 proquest_journals_2416521042 pubmed_primary_32409502 crossref_citationtrail_10_2337_dc20_0576 crossref_primary_10_2337_dc20_0576 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020-07-01 |
| PublicationDateYYYYMMDD | 2020-07-01 |
| PublicationDate_xml | – month: 07 year: 2020 text: 2020-07-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Alexandria |
| PublicationTitle | Diabetes care |
| PublicationTitleAlternate | Diabetes Care |
| PublicationYear | 2020 |
| Publisher | American Diabetes Association |
| Publisher_xml | – name: American Diabetes Association |
| References | Yuan (2022031300274559200_B15) Jiang (2022031300274559200_B33) 2020; 10 Morris (2022031300274559200_B31) 2007; 131 Yang (2022031300274559200_B37) 2020; 80 Cai (2022031300274559200_B5) Chen (2022031300274559200_B7) Xu (2022031300274559200_B32) 2017; 60 Wu (2022031300274559200_B38) Huang (2022031300274559200_B8) Bahammam (2022031300274559200_B26) 2012; 17 Dixon (2022031300274559200_B25) 2018; 12 Akinnusi (2022031300274559200_B29) 2008; 36 Qi (2022031300274559200_B12) Green (2022031300274559200_B3) 2017; 14 Xu (2022031300274559200_B34) 2017; 34 Morgan (2022031300274559200_B22) 2010; 5 Zammit (2022031300274559200_B27) 2010; 3 Liu (2022031300274559200_B10) 2020; 26 Lin (2022031300274559200_B9) 2020; 63 Tian (2022031300274559200_B36) 2020; 80 Ho (2022031300274559200_B39) 2009; 58 Cai (2022031300274559200_B6) Wu (2022031300274559200_B35) 2022031300274559200_B4 Metlay (2022031300274559200_B19) 2019; 200 2022031300274559200_B20 Poirier (2022031300274559200_B28) 2009; 120 Duarte (2022031300274559200_B30) 2007; 35 Sheridan (2022031300274559200_B2) 2012; 36 Shen (2022031300274559200_B13) Chen (2022031300274559200_B21) 2020; 395 Wang (2022031300274559200_B14) Liu (2022031300274559200_B11) 2020; 63 Baik (2022031300274559200_B24) 2000; 160 Louie (2022031300274559200_B23) 2011; 52 Zhao (2022031300274559200_B16) Lipsitch (2022031300274559200_B1) 2020; 382 WHO Expert Consultation (2022031300274559200_B17) 2004; 363 Bai (2022031300274559200_B18) 2020; 323 32958624 - Diabetes Care. 2020 Oct;43(10):e160-e161 |
| References_xml | – volume: 34 start-page: 1400 year: 2017 ident: 2022031300274559200_B34 article-title: Adiposity and incident diabetes within 4 years of follow-up: the Guangzhou Biobank Cohort Study publication-title: Diabet Med doi: 10.1111/dme.13378 – volume: 120 start-page: 86 year: 2009 ident: 2022031300274559200_B28 article-title: Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory from the American Heart Association publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.192575 – volume: 10 start-page: 1924 year: 2020 ident: 2022031300274559200_B33 article-title: Adiposity and mortality in older Chinese: an 11-year follow-up of the Guangzhou Biobank Cohort Study publication-title: Sci Rep doi: 10.1038/s41598-020-58633-z – ident: 2022031300274559200_B7 article-title: Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease publication-title: Br J Ophthalmol – ident: 2022031300274559200_B13 article-title: Treatment of 5 critically ill patients with COVID-19 with convalescent plasma publication-title: JAMA – volume: 395 start-page: 507 year: 2020 ident: 2022031300274559200_B21 article-title: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study publication-title: Lancet doi: 10.1016/S0140-6736(20)30211-7 – ident: 2022031300274559200_B38 article-title: Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention publication-title: JAMA – ident: 2022031300274559200_B4 doi: 10.15557/PiMR.2020.0003 – volume: 80 start-page: 401 year: 2020 ident: 2022031300274559200_B36 article-title: Characteristics of COVID-19 infection in Beijing publication-title: J Infect doi: 10.1016/j.jinf.2020.02.018 – volume: 160 start-page: 3082 year: 2000 ident: 2022031300274559200_B24 article-title: A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women publication-title: Arch Intern Med doi: 10.1001/archinte.160.20.3082 – volume: 12 start-page: 755 year: 2018 ident: 2022031300274559200_B25 article-title: The effect of obesity on lung function publication-title: Expert Rev Respir Med doi: 10.1080/17476348.2018.1506331 – volume: 80 start-page: 388 year: 2020 ident: 2022031300274559200_B37 article-title: Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China publication-title: J Infect doi: 10.1016/j.jinf.2020.02.016 – ident: 2022031300274559200_B15 article-title: PCR assays turned positive in 25 discharged COVID-19 patients publication-title: Clin Infect Dis – volume: 60 start-page: 2210 year: 2017 ident: 2022031300274559200_B32 article-title: The role of glycaemic and lipid risk factors in mediating the effect of BMI on coronary heart disease: a two-step, two-sample Mendelian randomisation study publication-title: Diabetologia doi: 10.1007/s00125-017-4396-y – ident: 2022031300274559200_B14 article-title: Clinical outcome of 55 asymptomatic cases at the time of hospital admission infected with SARS-Coronavirus-2 in Shenzhen, China publication-title: J Infect Dis – volume: 52 start-page: 301 year: 2011 ident: 2022031300274559200_B23 article-title: A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1) publication-title: Clin Infect Dis doi: 10.1093/cid/ciq152 – volume: 26 start-page: 1320 year: 2020 ident: 2022031300274559200_B10 article-title: Community transmission of severe acute respiratory syndrome coronavirus 2, Shenzhen, China, 2020 publication-title: Emerg Infect Dis doi: 10.3201/eid2606.200239 – volume: 3 start-page: 335 year: 2010 ident: 2022031300274559200_B27 article-title: Obesity and respiratory diseases publication-title: Int J Gen Med – volume: 200 start-page: e45 year: 2019 ident: 2022031300274559200_B19 article-title: Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America publication-title: Am J Respir Crit Care Med doi: 10.1164/rccm.201908-1581ST – volume: 36 start-page: 151 year: 2008 ident: 2022031300274559200_B29 article-title: Effect of obesity on intensive care morbidity and mortality: a meta-analysis publication-title: Crit Care Med doi: 10.1097/01.CCM.0000297885.60037.6E – ident: 2022031300274559200_B35 article-title: Clinical characteristics of imported cases of COVID-19 in Jiangsu province: a multicenter descriptive study publication-title: Clin Infect Dis – volume: 63 start-page: 364 year: 2020 ident: 2022031300274559200_B11 article-title: Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury publication-title: Sci China Life Sci doi: 10.1007/s11427-020-1643-8 – ident: 2022031300274559200_B16 article-title: Early virus clearance and delayed antibody response in a case of COVID-19 with a history of co-infection with HIV-1 and HCV publication-title: Clin Infect Dis – volume: 63 start-page: 606 year: 2020 ident: 2022031300274559200_B9 article-title: Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected patients publication-title: Sci China Life Sci doi: 10.1007/s11427-020-1668-5 – volume: 58 start-page: 439 year: 2009 ident: 2022031300274559200_B39 article-title: Prognostic factors for fatal adult influenza pneumonia publication-title: J Infect doi: 10.1016/j.jinf.2009.03.007 – ident: 2022031300274559200_B6 article-title: Characteristics of liver tests in COVID-19 patients publication-title: J Hepatol – ident: 2022031300274559200_B20 – volume: 14 start-page: S406 year: 2017 ident: 2022031300274559200_B3 article-title: Obesity impairs the adaptive immune response to influenza virus publication-title: Ann Am Thorac Soc doi: 10.1513/AnnalsATS.201706-447AW – volume: 131 start-page: 342 year: 2007 ident: 2022031300274559200_B31 article-title: The association between body mass index and clinical outcomes in acute lung injury publication-title: Chest doi: 10.1378/chest.06-1709 – ident: 2022031300274559200_B5 article-title: COVID-19 in a designated infectious diseases hospital outside Hubei Province, China publication-title: Allergy – volume: 35 start-page: 732 year: 2007 ident: 2022031300274559200_B30 article-title: Outcomes of morbidly obese patients requiring mechanical ventilation for acute respiratory failure publication-title: Crit Care Med doi: 10.1097/01.CCM.0000256842.39767.41 – ident: 2022031300274559200_B8 article-title: Application and effects of fever screening system in the prevention of nosocomial infection in the only designated hospital of coronavirus disease 2019 (COVID-19) in Shenzhen, China publication-title: Infect Control Hosp Epidemiol – volume: 323 start-page: 1406 year: 2020 ident: 2022031300274559200_B18 article-title: Presumed asymptomatic carrier transmission of COVID-19 publication-title: JAMA doi: 10.1001/jama.2020.2565 – volume: 382 start-page: 1194 year: 2020 ident: 2022031300274559200_B1 article-title: Defining the epidemiology of covid-19 - studies needed publication-title: N Engl J Med doi: 10.1056/NEJMp2002125 – volume: 36 start-page: 1072 year: 2012 ident: 2022031300274559200_B2 article-title: Obesity is associated with impaired immune response to influenza vaccination in humans publication-title: Int J Obes doi: 10.1038/ijo.2011.208 – volume: 17 start-page: 759 year: 2012 ident: 2022031300274559200_B26 article-title: Managing acute respiratory decompensation in the morbidly obese publication-title: Respirology doi: 10.1111/j.1440-1843.2011.02099.x – ident: 2022031300274559200_B12 article-title: Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses publication-title: Biochem Biophys Res Commun – volume: 5 start-page: e9694 year: 2010 ident: 2022031300274559200_B22 article-title: Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease publication-title: PLoS One doi: 10.1371/journal.pone.0009694 – volume: 363 start-page: 157 year: 2004 ident: 2022031300274559200_B17 article-title: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies publication-title: Lancet doi: 10.1016/S0140-6736(03)15268-3 – reference: 32958624 - Diabetes Care. 2020 Oct;43(10):e160-e161 |
| SSID | ssj0004488 |
| Score | 2.708515 |
| Snippet | Patients with obesity are at increased risk of exacerbations from viral respiratory infections. However, the association of obesity with the severity of... OBJECTIVE Patients with obesity are at increased risk of exacerbations from viral respiratory infections. However, the association of obesity with the severity... |
| SourceID | proquest pubmed crossref |
| SourceType | Aggregation Database Index Database Enrichment Source |
| StartPage | 1392 |
| SubjectTerms | Adult Betacoronavirus Body Mass Index Body weight Cardiovascular diseases China - epidemiology Chronic obstructive pulmonary disease Comorbidity Coronaviridae Coronavirus Infections - epidemiology Coronavirus Infections - physiopathology Coronaviruses Cough COVID-19 Diabetes Diabetes mellitus Epidemiology Female Fever Health services Hospitalization - statistics & numerical data Humans Hypertension Liver cancer Liver diseases Lung diseases Male Medical treatment Middle Aged Obesity Obesity - epidemiology Obesity - physiopathology Obstructive lung disease Odds Ratio Overweight Overweight - epidemiology Pandemics Patients Pneumonia, Viral - epidemiology Pneumonia, Viral - physiopathology Research design Respiratory diseases Risk Factors SARS-CoV-2 Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Signs and symptoms Underweight Viral diseases |
| Title | Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/32409502 https://www.proquest.com/docview/2416521042 https://www.proquest.com/docview/2404045154 |
| Volume | 43 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELZgSIgXNH6XDWQQD0hglsaOPT-ibtUG3aaJFPoWOY4Dm6YUba2E9tdz59hpkYI0eIkq23Xa--zzd7bvjpA3PLNGJk4ybZRkIksqZionmC2lwwhvIvUe3kfH8mAqPs2yWUw0HrxLFuUHe93rV_I_qEIZ4Ipesv-AbNcpFMBnwBeegDA8b4RxiOrvDwBGJ18P99hQw-yH_4GlZ807A_oEb2gY5JUxRQhWfPnhmuvgmNGl0I4kdS_ux-K1sNUhhT_3P4Wl7tfakBqFTkAu38-Xq_JvYR86N_NYNFn6bdmxCYtl2GsAwzLeS43qUfOMAQFpNabrKQs6tQ29FMaOWlOQQDjTPs2dcu_7X1l8aaZ6omMfnxTj6WRS5Puz_Da5k4JZgHrt8-ladHjh84x2v6iNJIVd73Qd_8k__mJUeHKRb5L7wSqgH1uIH5BbrnlI7h6Few-PyGFAmgLSNCJNI9L0rKGGrpCmEWmsiEi_px7nx2Q63s9HBywkwWCWK71gppRSZ06qBIiD5sPMllwpl-iytGg7c5GYCpRqBbxPC1W7tLaYJqDSFmwBw_kTstHMG_eMUFUlda3SWhqYhm5Yml2jza7FFAVu6KwekLdRNIUNEeIxUclFAZYiSrFAKRYoxQF53TX92YZF6Wu0HeVbhFlzVQBjlEAZYa0YkFddNeg0PKgyjZsvsQ0sLQKYthiQpy0u3VswgKTOkvT5Db69Re6tRvE22VhcLt0L4JCL8qUfOL8BQZpsFg |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Obesity+and+COVID-19+Severity+in+a+Designated+Hospital+in+Shenzhen%2C+China&rft.jtitle=Diabetes+care&rft.au=Cai%2C+Qingxian&rft.au=Chen%2C+Fengjuan&rft.au=Wang%2C+Tao&rft.au=Luo%2C+Fang&rft.date=2020-07-01&rft.issn=1935-5548&rft.eissn=1935-5548&rft.volume=43&rft.issue=7&rft.spage=1392&rft_id=info:doi/10.2337%2Fdc20-0576&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0149-5992&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0149-5992&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0149-5992&client=summon |